期刊文献+

急性早幼粒细胞白血病化疗后继发骨髓增生异常综合征一例并文献复习 被引量:3

Myelodysplastic syndrome secondary to acute promyelocytic leukemia after chemotherapy:report of one case and review of literature
原文传递
导出
摘要 目的分析急性早幼粒细胞白血病(APL)经治疗缓解后继发骨髓增生异常综合征(MDS)患者的临床特点,以提高对APL继发MDS的认识。方法回顾性分析江苏省苏北人民医院2013年9月收治的1例APL患者经治疗缓解后于2018年10月继发MDS的诊断及治疗经过,并复习相关文献。结果该患者初诊时确诊为APL,经标准治疗获得缓解。5年后因全血细胞减少再次就诊,经过骨髓相关检查,确诊MDS并再次行化疗治疗。结论APL治疗缓解后存在发生继发性MDS这一远期并发症可能,化疗结束后应定期、长期正规随访,改善患者预后。
作者 周爽 谢晓艳 何斌 顾健 Zhou Shuang;Xie Xiaoyan;He Bin;Gu Jian(Graduate School,Dalian Medical University,Dalian 116044,China;Department of Hematology,Subei People's Hospital of Jiangsu Province,Yangzhou 225001,China)
出处 《白血病.淋巴瘤》 CAS 2021年第1期55-57,共3页 Journal of Leukemia & Lymphoma
  • 相关文献

参考文献2

二级参考文献44

  • 1HERSHMAN D, NEUGUT A I,JACOBSON J S, et al. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy [J]. J Natl Cancer Inst,2007,99:196-205.
  • 2LE DELEY M C, SUZAN F, CUTULI B, et al. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer [J]. J Clin Oncol,2007,25;292-300.
  • 3KOLLMANNSBERGER C, HARTMANN J T,KANZ L, et al. Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies[J]. J Cancer Res Clin Oncol, 1998,124 : 207 - 214.
  • 4KOVITZ C, KANTARJIAN H, GARCIA-MANERO G,et al. Yelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia[J]. Blood, 2006,108 : 2811 - 2813.
  • 5LOBE I, RIGAL-HUGUET F, VEKHOFF A, et al. Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience [J]. Leukemia, 2003,17 : 1600 - 1604.
  • 6DELCANIZO M, AMIGO M, HERNdNDEZ J M, et al. Incidence and characterization of secondary myelo- dysplastic syndromes following autologous transplantation[J]. Haematologica, 2000,85 : 403 - 409.
  • 7KRISHNAN A, BHATIA S, SLOVAK M L, et al. Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors[J]. Blood,2000, 95:1588-1593.
  • 8ANDERSEN M K,JOHANSSON B,LARSEN S O,et al. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements [J]. Haematologica, 1998,83 : 483 - 488.
  • 9BLOOMFIELD C D, ARCHER K J, MRoZEK K, et al. 11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop [J]. Genes Chromosomes Cancer, 2002,33 : 362 - 378.
  • 10SLOVAK M L,BEDELL V,POPPLEWELL L, et al. 21q22 balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshop [J]. Genes Chromosomes Cancer, 2002,33:379-394.

共引文献19

同被引文献29

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部